Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke
Status:
Not yet recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
Ischemic stroke has a variety of treatments and currently drug therapy is one of the main
treatments.A number of clinical studies have proved that alprostadil (PGE1) has
pharmacological effects of significant dilation of blood vessels, inhibition of plate
aggregation, anti-atherosclerosis and increased cerebral blood flow.Evaluate the 90-days
efficacy by comparing two groups of patients'(one with alprostadil,another with placebo) mRS.
Phase:
Phase 4
Details
Lead Sponsor:
First Hospital of Jilin University The First Hospital of Jilin University